期刊文献+

基因表达谱结合共表达网络分析发现胰腺导管腺癌预后分子机制

Identify mechanism of the prognosis of pancreatic ductal adenocarcinoma using gene expression profiles and co-expression network analysis
原文传递
导出
摘要 目的 结合胰腺导管癌(PDAC)表达谱数据、临床资料以及分析基因共表达网络,定义PDAC预后相关的基因,并挖掘其预后相关的分子调控机制.方法 通过Cox生存分析寻找表达水平与生存时间相关的基因(P< 0.000 1).计算得到的相关基因之间的共表达关系,建立共表达网络,进一步寻找网络中核心模块.结果 Cox生存分析得到273个与患者的生存数据相关的候选基因,构建共表达网络[Pearson相关系数(r)> 0.9,P<0.05]寻找核心模块(MCODE算法,得分>2),最后发现1个包含6个基因(PTMAP7、FTSJ3、TLK2、GOLGA3、PTTG1IP、ZBTB37) 14个共表达关系的核心模块.其中GOLGA3基因已经被发现与PDAC的转移侵染有关;其他基因也都被研究发现属于已知癌基因.结论 构建的PDAC相关基因的共表达模块与PDAC预后相关,且可能作为PDAC预后相关标志分子. Objective To detect genes expression related to the prognosis of pancreatic ductal adenocarcinoma (PDAC) and explore the potential molecular mechanism applying PDAC gene expression data,co-expression network and clinical data.Methods Univariate Cox proportional hazards model was used to find genes which were significantly correlated with patient survival data (P < 0.000 1).Then calculated the correlation coefficient of these genes to establish co-expression network and found key modules of the network.Results 273 candidate genes were found related to survival data.With these genes,genes co-expression network (Pearson correlation r > 0.9,P < 0.05) and key modules were constructed,and then,a key module including 6 genes (PTMAP7,FTSJ3,TLK2,GOLGA3,PTTG1IP,ZBTB37) and 14 co-expression relationships between them were found.Among these genes,GOLGA3 had been known to associate with invasion and metastasis of PDAC,and the other 5 genes were all known as cancer genes.Conclusion These findings may suggest that these 6 survival genes in the key module of co-expression network are highly associated with the prognosis of PDAC,and may be biomarkers for PDAC prognosis.
出处 《肿瘤研究与临床》 CAS 2014年第9期583-586,共4页 Cancer Research and Clinic
关键词 胰腺管 共表达网络 预后 分子机制 Neoplasms, pancreatic ductal Co-expression network Prognosis Molecular mechanism
  • 相关文献

参考文献2

二级参考文献30

  • 1李淑德,许国铭,张洪富.胃癌患者血清可溶性白细胞介素-2受体初步研究[J].中华消化杂志,1994,14(6):323-325. 被引量:9
  • 2张方信,梁守德,邓芝云,于兰,杨霄鹏.原发性与转移性肝癌病人LAK活性、IL-2水平及sIL-2R表达[J].兰州医学院学报,1995,21(1):24-25. 被引量:1
  • 3高云朝,辛丽君,顾建英,陆汉魁.转移性肝癌患者血清肿瘤标志物对比分析[J].临床检验杂志,2007,25(1):60-61. 被引量:3
  • 4艾书跃,吴建伟,吕毛古,王灵枝,杨军,黄伟,袁梅.^(18)F-FDG PET/CT显像在肝脏恶性肿瘤的初步应用[J].临床肿瘤学杂志,2007,12(4):279-281. 被引量:12
  • 5Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg, 2000, 87: 236-242.
  • 6Miyazaki M, Itoh H, Nakagawa K, at al. Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol, 1997, 92: 490- 493.
  • 7Rubin LA, Kurman CC, Fritz ME, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J, 1985, 135: 3172-3177.
  • 8Bandorowiez-PikulaJ.Annexin的生物学及病理学意义.张树汉,颜宏利,王芳,等,译.上海:第二军医大学出版社,2005:9.
  • 9Wu Y, Yamada S, Izumi H, et al. Strong YB-1 expression is associated with liver metastasis progression and predicts shorter disease-free survival in advanced gastric cancer. J Snrg Oncol, 2012, 105: 724-730.
  • 10Imdahl A, Reinhardt MJ, Nitzsche EU, et al. Impact of 18F-FDG- positron emission tomography for decision making in colorectal cancer recurrences. Langenbecks Arch Surg, 2000, 385:129-134.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部